Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €114.00. The company’s shares closed yesterday ...

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Sanofi India Limited, (Previously known as Aventis Pharma Limited ... In May 2007, the company launched a line extension, Amaryl M. A new granulation train dedicated for production of Combiflam ...

Sanofi estimates that the annual cost for a typical patient will be around $280,000 per year before discounts or rebates, in line with other drugs used to treat rare, chronic diseases.

The new logo – which consists of a yellow number 5 on a blue background – will be used by the channel from today (Wednesday 12th March) onwards. It comes after the broadcaster announced that ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zohran Mamdani, Zellnor Myrie and Jessica Ramos are ping-ponging between New York City and Albany as they divide their time between legislating and campaigning. On Sunday, the runners will go over ...

In the aftermath of the Oscars, a new slate of blockbusters and indie films are hoping to drum up excitement about what 2025 has to offer in the cinema landscape. Starting with the weekend’s ...